DNMT1 and colorectal cancer: Finally, while CIITA promoter methylation appears not to be an important mechanism of tsMHC-II loss in colorectal cancer, multiple other immune-related genes may be repressed by promoter methylation, including endogenous retroviral genes and thus the combination of DNMT inhibitors with checkpoint blockade has been studied.